EU approves Novovax coronavirus vaccine: COVID stay information | Coronavirus pandemic News

The European Union has approved the Novovax vaccine for use, the fifth jab so significantly,  as nations in the region fight with surge in new scenarios.

The 27 nation bloc has so far previously permitted the Pfizer, Moderna, Astrazeneca and Johnson & Johnson vaccines.

Israel has added the United States to its “no-fly” list, citing worries about the unfold of the new Omicron coronavirus variant.

Acting on overall health ministry recommendations, Israeli cupboard ministers voted on Monday to set the United States, Italy, Belgium, Germany, Hungary, Morocco, Portugal, Canada, Switzerland and Turkey on the no-fly roster.

In Europe, Germany has ruled out a Christmas lockdown but warned a fifth COVID-19 wave could no for a longer time be stopped amid the unfold of Omicron.

Here are the most up-to-date updates:

16 mins in the past (13:45 GMT)

Preliminary booster details demonstrates superior final results on new variant: Moderna

Moderna says a booster dose of its COVID-19 vaccine should really offer you safety towards the speedily spreading omicron variant.

The company explained lab checks confirmed the fifty percent-dose booster shot greater by 37 occasions the stage of so-identified as neutralising antibodies ready to battle omicron.

And a whole-dose booster was even more robust, triggering an 83-fold bounce in antibody amounts, while with an maximize in the standard side outcomes, the company claimed.

Regardless of half-dose photographs are becoming made use of for most Moderna boosters, a total-dose 3rd shot has been advised for individuals with weakened immune programs [File: Rogelio V. Solis/AP Photo]

---

41 mins ago (13:20 GMT)

EU approves 5th COVID-19 vaccine for bloc, just one by Novavax

The European Union’s medications regulator gave the inexperienced light-weight to a fifth COVID-19 vaccine for use in the 27-nation bloc, granting conditional advertising authorization to the two-dose vaccine built by US biotech corporation Novavax.

The European Medications Agency conclusion to grant conditional advertising authorisation for the vaccine for men and women aged 18 and over, which must be confirmed by the EU’s executive commission, comes as several European nations are battling surges in infections and amid concerns about the spread of the new omicron variant.

---

2 hours ago (12:00 GMT)

Dubai airport fully operational for…